BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Microbiome Times Magazine - ECPv6.11.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.microbiometimes.com
X-WR-CALDESC:Events for Microbiome Times Magazine
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Athens
BEGIN:DAYLIGHT
TZOFFSETFROM:+0200
TZOFFSETTO:+0300
TZNAME:EEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0300
TZOFFSETTO:+0200
TZNAME:EET
DTSTART:20191027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190722
DTEND;VALUE=DATE:20190725
DTSTAMP:20260422T234008
CREATED:20190403T122528Z
LAST-MODIFIED:20190403T122528Z
UID:2537-1563753600-1564012799@www.microbiometimes.com
SUMMARY:Microbiome Movement – Oncology Response Summit
DESCRIPTION:The inaugural Microbiome Movement – Oncology Response Summit has been established to improve your understanding on how to translate microbiome-oncology research from discovery settings and from retrospective clinical investigations into the routine oncology practice. This first-of-its-kind event is your opportunity to learn from the expertise of key opinion leaders from pre-clinical\, translational and clinical scientists from large pharma\, biotech and academia presenting the latest case studies and in-depth discussion on key topics including: \n\nDiscover the mechanistic pathways underpinning the causality of the microbiome in cancer and consequential effects of cancer therapeutics on microbial dysbiosis\nUnderstand how –omics data are being integrating to inform cancer clinical decision making\nInvestigate translational applications of the microbiome in cancer 1) to improve clinical safety outcomes\, 2) as a validated biomarker to predict patient response and 3) as an LBP monotherapy or adjuvant to enhance therapeutic efficacy (particularly in the context of immunotherapy)\nExplore the nutritional interventions for cancer treatment and prevention\nHarness clinical experience to establish gold standards for cancer clinical trials incorporating the microbiome as a measurable endpoint\nUncover how to integrate the microbiome into existing oncology medical practice and drug development infrastructures\n\nReceive an exclusive 20% discount on your registration when quoting VIP Code 13017MBT. \nVisit the website to learn more.
URL:https://www.microbiometimes.com/event/microbiome-movement-oncology-response-summit/
LOCATION:Boston\, MA\, United States
ATTACH;FMTTYPE=image/png:https://www.microbiometimes.com/wp-content/uploads/2019/04/MM-Oncology-Social-Banner.png
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR